Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
NCT07104487Phase 2Recruiting
- Sponsor
- UZ Leuven
- Start
- Mar 2025
- Primary completion
- Sep 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 18F-AlF-NOTA-octreotide in carotid atheroma (CAS), sponsored by UZ Leuven. Started Mar 2025; status: recruiting.
02
Drugs
18F-AlF-NOTA-octreotide
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on NCT07104487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07104487.